Niels Fristrup

7PUBLICATIONS
20CO-AUTHORS
PharmacogenomicsMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 27, 2026
Development and Validation of an LC-MS/MS Method for Simultaneous Quantification of Pazopanib, Cabozantinib, Sorafenib, Axitinib, Tivozanib, Sunitinib, and the Metabolites Sorafenib N-Oxide and Desethyl-Sunitinib in Human Plasma.

|Jun 03, 2025
Therapeutic drug monitoring (TDM) of tyrosine kinase inhibitors (TKI) for optimized outcome in patients with metastatic renal cell carcinoma. The TKI-TDM Trial. Study protocol.

Jakob N Henriksen, Charlotte U Andersen, Frede Donskov

|May 14, 2025
Trends in kidney cancer: exploring the impact of sex and age on stage of disease, and prognosis during the past three decades in Denmark-a DaRenCa study.

Johanne Ahrenfeldt, Jesper Jespersen, Jens Ejrnæs Lyngstrand

|Aug 19, 2024
Recurrence patterns following nephrectomy for renal cell carcinoma in a Danish nationwide cohort.

Goran Bencina, Rolf Billeskov, Rasmine Bak

|Mar 28, 2024
Cytoreductive Nephrectomy in Select Primary Metastatic Renal Cell Carcinoma Patients: A Comprehensive Nationwide Outcome Analysis.

Nessn Azawi, Louise Geertsen, Naomi Nadler

|Oct 24, 2023
Management of Renal Cell Carcinoma: Promising Biomarkers and the Challenges to Reach the Clinic.

Iben Lyskjær, Laura Iisager, Christian Tang Axelsen

Pageof 2

Frequent Collaborators

3 joint publications

Nessn Azawi

3 joint publications

Frede Donskov

2 joint publications

Susanne Oksbjerg Dalton

2 joint publications

Iben Lyskjær